Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **cervical extracellular matrix** is the ensemble of molecules (primarily collagens I, III, IV, VI, elastin, fibronectin, laminin, proteoglycans, and enzymes like matrix metalloproteinases) that form the scaffolding and microenvironment of the uterine cervix. It determines the mechanical strength of the cervix (mainly via collagen), coordinates elasticity (via elastin), and modulates cell adhesion, migration, and response to physiological changes, especially during pregnancy, labor, and disease such as cancer. Changes in ECM composition and structure are central to cervical function, remodeling, and pathology. ECM components interact with cellular receptors (integrins, DDRs), act as reservoirs for growth factors, and play crucial roles in wound healing, tissue integrity, and disease progression.
For drugs targeting ECM components: - Inhibition of matrix metalloproteinase activity (blocks ECM degradation/remodeling) - Modulation of collagen synthesis or cross-linking - Blocking or mimicking ECM proteins/receptors (e.g., integrin antagonists in research)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cervical extracellular matrix (None).